884507-44-2 Usage
Description
1-(3-IODOBENZYL)PYRROLIDINE is a chemical compound that belongs to the class of organic compounds known as pyrrolidines. It is characterized by a pyrrolidine ring with a 3-iodobenzyl group attached to it, which contributes to its potential applications in various industries.
Uses
Used in Pharmaceutical Industry:
1-(3-IODOBENZYL)PYRROLIDINE is used as an intermediate in organic synthesis for the production of pharmaceuticals. Its unique structure allows for the development of drugs targeting a range of diseases and conditions, making it a valuable component in the creation of novel therapeutic agents.
Used in Agrochemical Industry:
In the agrochemical industry, 1-(3-IODOBENZYL)PYRROLIDINE is utilized as an intermediate in the synthesis of various agrochemicals. Its role in the development of these chemicals aids in enhancing agricultural productivity and protecting crops from pests and diseases.
Used in Organic Synthesis:
1-(3-IODOBENZYL)PYRROLIDINE is also used as a building block in the synthesis of other complex organic molecules. Its presence in these molecules can lead to the creation of new compounds with diverse applications, further expanding the utility of this chemical compound.
Check Digit Verification of cas no
The CAS Registry Mumber 884507-44-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,4,5,0 and 7 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 884507-44:
(8*8)+(7*8)+(6*4)+(5*5)+(4*0)+(3*7)+(2*4)+(1*4)=202
202 % 10 = 2
So 884507-44-2 is a valid CAS Registry Number.
InChI:InChI=1/C11H14IN/c12-11-5-3-4-10(8-11)9-13-6-1-2-7-13/h3-5,8H,1-2,6-7,9H2
884507-44-2Relevant articles and documents
C8-substituted pyrido[3,4-d]pyrimidin-4(3H)-ones: Studies towards the identification of potent, cell penetrant Jumonji C domain containing histone lysine demethylase 4 subfamily (KDM4)inhibitors, compound profiling in cell-based target engagement assays
Le Bihan, Yann-Va?,Lanigan, Rachel M.,Atrash, Butrus,McLaughlin, Mark G.,Velupillai, Srikannathasan,Malcolm, Andrew G.,England, Katherine S.,Ruda, Gian Filippo,Mok, N. Yi,Tumber, Anthony,Tomlin, Kathy,Saville, Harry,Shehu, Erald,McAndrew, Craig,Carmichael, LeAnne,Bennett, James M.,Jeganathan, Fiona,Eve, Paul,Donovan, Adam,Hayes, Angela,Wood, Francesca,Raynaud, Florence I.,Fedorov, Oleg,Brennan, Paul E.,Burke, Rosemary,van Montfort, Rob L.M.,Rossanese, Olivia W.,Blagg, Julian,Bavetsias, Vassilios
supporting information, p. 316 - 337 (2019/06/05)
Residues in the histone substrate binding sites that differ between the KDM4 and KDM5 subfamilies were identified. Subsequently, a C8-substituted pyrido[3,4-d]pyrimidin-4(3H)-one series was designed to rationally exploit these residue differences between
5-Membered heterocyclic compound
-
Page/Page column 57, (2009/07/03)
The present invention provides 5-membered heterocycle compounds represented by the following general formula (I): The present compounds have a superior acid secretion inhibitory effect, and shows an antiulcer activity and the like.
